If you are:
Only When Necessary: NEONATAL WITHDRAWAL/RESP.DEPRESS. W/CHRONIC OR HIGH DOSE; SMALL TERATOGENIC RISK
Precaution: MONITOR INFANT FOR RESPIRATORY DEPRESSION AND INCREASED DROWSINESS
An adult over 60:
management or monitoring precaution: Pulmonary-Life threatening respiratory depression is more likely to occur with high doses, SR products, cachexia, or debilitation due to altered pharmacokinetics with poor fat stores, muscle wasting, or altered clearance. Monitor closely at initiation and with dose titration. Neuro/Psych-Risk for increased confusion and delirium. May increase fall risk. Avoid treatment with 3 or more CNS active drugs. Gastrointestinal-Constipation risk. Urogenital-Urinary retention risk.
Giving morphine SULFATE ER Capsule, Extended Release Multiphase 24 hr to a child under 12:
Severe Precaution: Potential increased risk of respiratory and CNS depression, gastrointestinal adverse effects. Safety and effectiveness of extended release product not established.
Severe Precaution: Potential increased sensitivity to effects, adverse CNS effects and respiratory depression.